<
 / Physicians

Temporary product change: Lorazepam 4 mg /mL X 1 mL vials

Date

The issue: Due to the shortage of Canadian-labelled lorazepam 4 mg/mL X 1 mL vials from Sandoz, Health Canada has authorized the importation of a US-labelled product from Hikma. NH pharmacy may need to bring in supply of this US-labelled product available if the resolution date gets extended past November.   

Further information and practice implications
 

Share this page